Shigemi Matsuyama

Title: Shigemi Matsuyama: Innovator in Neuronal Cell Protection

Introduction

Shigemi Matsuyama is a notable inventor based in Beachwood, OH (US). He has made significant contributions to the field of cell biology, particularly in the area of neuronal cell protection. With a total of 4 patents to his name, Matsuyama's work focuses on innovative methods to inhibit cell death and apoptosis.

Latest Patents

Matsuyama's latest patents include groundbreaking research on Bax inhibitors and their applications. One of his notable inventions is a compound having formula (I) or (II) for use in inhibiting Bax-mediated cell death and/or apoptosis. Additionally, he has developed methods involving IFNγR2 compositions aimed at inhibiting neuronal cell death. This method includes administering a therapeutically effective amount of a cell-penetrating peptide (CPP) to neuronal cells exposed to neurotoxic amounts of β-amyloid (Aβ). The CPP has an amino acid sequence that maintains at least 80% sequence identity to about 5 to about 41 consecutive amino acids of SEQ ID NO: 1.

Career Highlights

Shigemi Matsuyama is affiliated with Case Western Reserve University, where he continues to advance his research in cell biology. His work has garnered attention for its potential applications in treating neurodegenerative diseases.

Collaborations

Matsuyama collaborates with William Greenlee, contributing to the advancement of their shared research interests.

Conclusion

Shigemi Matsuyama's innovative work in the field of neuronal cell protection highlights his commitment to advancing scientific knowledge and developing therapeutic solutions. His contributions are paving the way for future research and potential treatments for neurodegenerative conditions.